Daiichi Sankyo Hits Day Low of JPY 2,488 Amid Price Pressure

Daiichi Sankyo Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced significant market activity on April 24, 2026, with its stock declining by 10.43%. The stock reached an intraday low of JPY 2,488.00, reflecting a challenging trading day for the company. Over the past week, Daiichi Sankyo's performance has been notably weak, with a decline of 14.97%, and a more pronounced drop of 16.98% over the past month. Year-to-date, the stock has fallen by 25.36%, and its one-year performance shows a decrease of 24.64%. This consistent underperformance is evident when compared to the Japan Nikkei 225, which has shown positive returns across the same periods. Despite these challenges, Daiichi Sankyo maintains a net-debt-free status and has reported healthy long-term growth in net sales and operating profit. The company's return on equity stands at 18.22%, and it trades at a price-to-book value of 4.17, indicating an attractive valuation relative to its peers. However, the stock's performance has lagged behind the benchmark index over the last three years, highlighting ongoing market pressures.